Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
07 Jul 2024 |
AA |
Full accounts made up to 31 March 2023
|
|
|
20 Jun 2024 |
CS01 |
Confirmation statement made on 16 June 2024 with no updates
|
|
|
01 Jun 2024 |
DISS40 |
Compulsory strike-off action has been discontinued
|
|
|
28 May 2024 |
GAZ1 |
First Gazette notice for compulsory strike-off
|
|
|
19 Feb 2024 |
CH01 |
Director's details changed for Ms Seyda Atadan Memis on 1 September 2023
|
|
|
11 Jan 2024 |
AD02 |
Register inspection address has been changed from 100 New Bridge Street London EC4V 6JA United Kingdom to 280 Bishopsgate London EC2M 4RB
|
|
|
22 Jun 2023 |
AD03 |
Register(s) moved to registered inspection location 100 New Bridge Street London EC4V 6JA
|
|
|
21 Jun 2023 |
AD02 |
Register inspection address has been changed to 100 New Bridge Street London EC4V 6JA
|
|
|
21 Jun 2023 |
CS01 |
Confirmation statement made on 16 June 2023 with updates
|
|
|
26 Jan 2023 |
TM01 |
Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023
|
|
|
03 Jan 2023 |
AA |
Group of companies' accounts made up to 31 March 2022
|
|
|
10 Nov 2022 |
TM01 |
Termination of appointment of Mark Gibbons as a director on 8 November 2022
|
|
|
29 Sep 2022 |
TM01 |
Termination of appointment of Heather Adkins Huet as a director on 22 July 2022
|
|
|
23 Aug 2022 |
AP01 |
Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022
|
|
|
11 Aug 2022 |
SH01 |
Statement of capital following an allotment of shares on 1 August 2022
|
|
|
11 Aug 2022 |
MA |
Memorandum and Articles of Association
|
|
|
11 Aug 2022 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES13 ‐
Company business 01/08/2022
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
11 Aug 2022 |
SH10 |
Particulars of variation of rights attached to shares
|
|
|
09 Aug 2022 |
MR04 |
Satisfaction of charge 102384250001 in full
|
|
|
20 Jul 2022 |
CS01 |
Confirmation statement made on 16 June 2022 with updates
|
|
|
22 Apr 2022 |
SH01 |
Statement of capital following an allotment of shares on 5 April 2022
|
|
|
20 Apr 2022 |
AP01 |
Appointment of Dr Emma Jane Roffe as a director on 5 April 2022
|
|
|
20 Apr 2022 |
AP01 |
Appointment of Mr Jonathan Clark Neal as a director on 5 April 2022
|
|
|
19 Apr 2022 |
PSC05 |
Change of details for Takeda Pharmaceutical Company Limited as a person with significant control on 5 April 2022
|
|
|
19 Apr 2022 |
PSC07 |
Cessation of Abingworth Bioventures Vi Gp Lp as a person with significant control on 5 April 2022
|
|